Literature DB >> 23927994

Absolute monocyte count in follicular lymphoma patients treated with rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone.

Reina Watanabe1, Naoto Tomita, Kumiko Kishimoto, Satoshi Koyama, Eriko Ogusa, Yoshimi Ishii, Kazuho Miyashita, Shiro Matsuura, Shin Fujisawa, Yukako Hattori, Hirotaka Takasaki, Atsuko Fujita, Rika Ohshima, Hideyuki Kuwabara, Chizuko Hashimoto, Katsumichi Fujimaki, Rika Sakai, Yoshiaki Ishigatsubo.   

Abstract

Elevated absolute monocyte counts (AMCs) have been reported to indicate poor prognosis for patients with lymphoproliferative disease, including those with follicular lymphoma (FL) receiving various treatments. We evaluated the prognostic impact of AMC in 150 consecutive FL patients who received rituximab plus cyclophosphamide, doxorubicin, vincristine, and prednisone (R-CHOP) therapy. Progression-free survival (PFS) did not differ significantly according to the AMC level. Univariate and multivariate analyses did not indicate a prognostic significance of AMC for PFS. Thus, the AMC is not a prognostic factor for FL patients treated with R-CHOP. However, immunochemotherapy might influence the prognostic impact of AMC.
Copyright © 2013 Elsevier Ltd. All rights reserved.

Entities:  

Keywords:  Follicular lymphoma; Monocyte; Prognosis

Mesh：

Substances：

Year:  2013        PMID： 23927994     DOI： 10.1016/j.leukres.2013.07.015

Source DB:  PubMed          Journal:  Leuk Res        ISSN： 0145-2126            Impact factor:   3.156


  10 in total

1.  The Role of Lymphocyte to Monocyte Ratio, Microvessel Density and HiGH CD44 Tumor Cell Expression in Non Hodgkin Lymphomas.

Authors:  Jelena Jelicic; Milena Todorovic Balint; Maja Perunicic Jovanovic; Novica Boricic; Marjan Micev; Jelena Stojsic; Darko Antic; Bosko Andjelic; Jelena Bila; Bela Balint; Sonja Pavlovic; Biljana Mihaljevic
Journal:  Pathol Oncol Res       Date:  2016-01-11       Impact factor: 3.201

2.  Ratio of peripheral blood absolute lymphocyte count to absolute monocyte count at diagnosis is associated with progression-free survival in follicular lymphoma.

Authors:  Shogo Kumagai; Masaharu Tashima; Jun Fujikawa; Makoto Iwasaki; Yoshihiro Iwamoto; Yuki Sueki; Akiko Fukunaga; Soshi Yanagita; Momoko Nishikori; Akifumi Takaori-Kondo; Nobuyoshi Arima
Journal:  Int J Hematol       Date:  2014-04-23       Impact factor: 2.490

3.  Nomogram prediction of overall survival for patients with non-small-cell lung cancer incorporating pretreatment peripheral blood markers.

Authors:  Dong Xie; Mark S Allen; Randolph Marks; Gening Jiang; Zhifu Sun; Frances Nichols; Mingrui Zhang; Chang Chen; Marie-Christine Aubry; Aminah Jatoi; Yolanda I Garces; Aaron Mansfield; Dennis Wigle; Julian Molina; Claude Deschamps; Ping Yang
Journal:  Eur J Cardiothorac Surg       Date:  2018-06-01       Impact factor: 4.191

4.  FCG (FLIPI, Charlson comorbidity index, and histological grade) score is superior to FLIPI in advanced follicular lymphoma.

Authors:  Biljana Mihaljevic; Jelena Jelicic; Bosko Andjelic; Darko Antic; Olivera Markovic; Ivan Petkovic; Maja Perunicic Jovanovic; Goran Trajkovic; Jelena Bila; Vladislava Djurasinovic; Aleksandra Sretenovic; Vojin Vukovic; Mihailo Smiljanic; Milena Todorovic Balint
Journal:  Int J Hematol       Date:  2016-10-06       Impact factor: 2.490

5.  Imaging of Early Response to Predict Prognosis in the First-Line Management of Follicular Non-Hodgkin Lymphoma with Iodine-131-Rituximab Radioimmunotherapy.

Authors:  Murali Kesavan; Jan Boucek; William MacDonald; Andrew McQuillan; J Harvey Turner
Journal:  Diagnostics (Basel)       Date:  2017-05-12

Review 6.  The Neutrophil to Lymphocyte and Lymphocyte to Monocyte Ratios as New Prognostic Factors in Hematological Malignancies - A Narrative Review.

Authors:  Paulina Stefaniuk; Agnieszka Szymczyk; Monika Podhorecka
Journal:  Cancer Manag Res       Date:  2020-04-29       Impact factor: 3.989

Review 7.  Follicular Lymphoma Microenvironment: An Intricate Network Ready for Therapeutic Intervention.

Authors:  Cèlia Dobaño-López; Ferran Araujo-Ayala; Neus Serrat; Juan G Valero; Patricia Pérez-Galán
Journal:  Cancers (Basel)       Date:  2021-02-05       Impact factor: 6.639

8.  Clinical and biological prognostic factors in follicular lymphoma patients.

Authors:  Ádám Jóna; Anna Kenyeres; Sándor Barna; Árpád Illés; Zsófia Simon
Journal:  PLoS One       Date:  2022-08-04       Impact factor: 3.752

9.  Peripheral blood lymphocyte/monocyte ratio at the time of first relapse predicts outcome for patients with relapsed or primary refractory diffuse large B-cell lymphoma.

Authors:  Yan-Li Li; Kang-Sheng Gu; Yue-Yin Pan; Yang Jiao; Zhi-Min Zhai
Journal:  BMC Cancer       Date:  2014-05-19       Impact factor: 4.430

10.  Absolute B cell counts in blood predict long-term response in follicular lymphoma patients treated with rituximab without chemotherapy.

Authors:  Henna-Riikka Junlén; Sandra Lockmer; Eva Kimby; Björn Engelbrekt Wahlin
Journal:  Ann Hematol       Date:  2020-08-17       Impact factor: 3.673
  10 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.